Amanda Murphy

Amanda Murphy

+1 312 364 8951
E-mail vCard

Specialties:  Diagnostic Services, Life Sciences

Amanda Murphy, CFA, partner, joined William Blair & Company in 2006. Ms. Murphy is a healthcare analyst with a focus on diagnostic services and life sciences. Previously, Ms. Murphy worked at Caremark as a business analyst and as a senior consultant within PricewaterhouseCoopers’s strategy consulting division. She received a B.S. in biology from Boston College’s honors program and holds an MBA in finance, accounting, and economics from the Kellogg Graduate School of Management at Northwestern University.

Repligen Corporation: Initiation of Research Coverage

William Blair & Company initiated research coverage of Repligen Corporation (RGEN). Repligen is a bioprocessing company focused on providing technology and solutions that facilitate manufacturing of complex therapeutics, particularly monoclonal antibodies, which make up 75% of total revenue. Learn More

Invitae Corporation: Initiation of Research Coverage

William Blair & Company initiated research coverage of Invitae Corporation (NVTA $8.84), a genetic information company, which offers a 221-gene, next-generation sequencing-based test menu via its CLIA-certified and CAP-accredited laboratory in San Francisco, California. Learn More

Spring 2015 Survey of Biopharmaceutical Sponsors

To monitor the broad trends in pharmaceutical outsourcing and identify changing attitudes about the leading vendors, William Blair healthcare analysts have conducted several industry surveys over the past decade. Learn More